197 related articles for article (PubMed ID: 24991022)
1. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms.
Paci E; Broeders M; Hofvind S; Puliti D; Duffy SW;
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1159-63. PubMed ID: 24991022
[TBL] [Abstract][Full Text] [Related]
2. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet.
Paci E;
J Med Screen; 2012; 19 Suppl 1():5-13. PubMed ID: 22972806
[TBL] [Abstract][Full Text] [Related]
3. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
Broeders M; Paci E
Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
[TBL] [Abstract][Full Text] [Related]
4. Benefit-to-harm ratio of the Danish breast cancer screening programme.
Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
[TBL] [Abstract][Full Text] [Related]
5. Benefits and harms of mammography screening.
Løberg M; Lousdal ML; Bretthauer M; Kalager M
Breast Cancer Res; 2015 May; 17(1):63. PubMed ID: 25928287
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.
Njor S; Nyström L; Moss S; Paci E; Broeders M; Segnan N; Lynge E;
J Med Screen; 2012; 19 Suppl 1():33-41. PubMed ID: 22972809
[TBL] [Abstract][Full Text] [Related]
8. [Breast cancer screening in Austria: Key figures, age limits, screening intervals and evidence].
Jeitler K; Semlitsch T; Posch N; Siebenhofer A; Horvath K
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):363-70. PubMed ID: 26354136
[TBL] [Abstract][Full Text] [Related]
9. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
Pace LE; Keating NL
JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
[TBL] [Abstract][Full Text] [Related]
10. The value of modern mammography screening in the control of breast cancer: understanding the underpinnings of the current debates.
Smith RA
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1139-46. PubMed ID: 24991021
[TBL] [Abstract][Full Text] [Related]
11. Quantifying the benefits and harms of screening mammography.
Welch HG; Passow HJ
JAMA Intern Med; 2014 Mar; 174(3):448-54. PubMed ID: 24380095
[TBL] [Abstract][Full Text] [Related]
12. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
[TBL] [Abstract][Full Text] [Related]
13. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
US Preventive Services Task Force
Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
[TBL] [Abstract][Full Text] [Related]
14. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.
Winch CJ; Sherman KA; Boyages J
Breast Cancer Res Treat; 2015 Jan; 149(1):211-21. PubMed ID: 25476499
[TBL] [Abstract][Full Text] [Related]
15. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.
Puliti D; Duffy SW; Miccinesi G; de Koning H; Lynge E; Zappa M; Paci E;
J Med Screen; 2012; 19 Suppl 1():42-56. PubMed ID: 22972810
[TBL] [Abstract][Full Text] [Related]
16. Quality-of-life effects of screening mammography in Norway.
Zahl PH; Kalager M; Suhrke P; Nord E
Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
[TBL] [Abstract][Full Text] [Related]
17. Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer.
Ripping TM; Hubbard RA; Otten JD; den Heeten GJ; Verbeek AL; Broeders MJ
Int J Cancer; 2016 Apr; 138(7):1619-25. PubMed ID: 26537645
[TBL] [Abstract][Full Text] [Related]
18. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
Matkowski R; Szynglarewicz B
Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
[TBL] [Abstract][Full Text] [Related]
19. United States Preventive Services Task Force screening mammography recommendations: science ignored.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
[TBL] [Abstract][Full Text] [Related]
20. Mammography screening. Benefits, harms, and informed choice.
Jørgensen KJ
Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
